BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36806511)

  • 1. Associations Between Levels of Peripheral NCAPH2 Promoter Methylation and Different Stages of Alzheimer's Disease: A Cross-Sectional Study.
    Hao SW; Li TR; Han C; Han Y; Cai YN
    J Alzheimers Dis; 2023; 92(3):899-909. PubMed ID: 36806511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer's disease and amnesic mild cognitive impairment patients.
    Shinagawa S; Kobayashi N; Nagata T; Kusaka A; Yamada H; Kondo K; Nakayama K
    Neurosci Lett; 2016 Aug; 629():33-37. PubMed ID: 27356276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
    Xie B; Xu Y; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
    J Alzheimers Dis; 2017; 56(1):391-401. PubMed ID: 27935556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    Kobayashi N; Shinagawa S; Nagata T; Shimada K; Shibata N; Ohnuma T; Kasanuki K; Arai H; Yamada H; Nakayama K; Kondo K
    PLoS One; 2016; 11(1):e0146449. PubMed ID: 26742120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood
    Chen Y; Li TR; Hao SW; Wang XN; Cai YN; Han Y
    Front Aging Neurosci; 2021; 13():632382. PubMed ID: 33603659
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
    Xie B; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
    J Alzheimers Dis; 2017; 58(1):263-274. PubMed ID: 28387675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of plasma BDNF levels with different stages of Alzheimer's disease: a cross-sectional study.
    Wang T; Li T; Hao S; Han Y; Cai Y
    Neurol Res; 2023 Mar; 45(3):234-240. PubMed ID: 36453692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population.
    Dong QY; Li TR; Jiang XY; Wang XN; Han Y; Jiang JH
    Alzheimers Res Ther; 2021 Apr; 13(1):74. PubMed ID: 33827675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Androgens and Gonadotropins with Amnestic Mild Cognitive Impairment and Probable Alzheimer's Disease in Chinese Elderly Men.
    Li Y; Li S; Xu S; Yu H; Tang L; Liu X; Wang X; Zhang Y; Zhang K; Mi S; Chen M; Cui H
    J Alzheimers Dis; 2020; 78(1):277-290. PubMed ID: 32986665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer's disease: a cross-sectional study.
    Wang T; Wang X; Yao Y; Zhao C; Yang C; Han Y; Cai Y
    BMJ Open; 2022 Apr; 12(4):e054347. PubMed ID: 35387811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
    J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tactile Angle Discrimination Decreases due to Subjective Cognitive Decline in Alzheimer's Disease.
    Zhang Z; Chen G; Zhang J; Yan T; Go R; Fukuyama H; Wu J; Han Y; Li C
    Curr Alzheimer Res; 2020; 17(2):168-176. PubMed ID: 32148194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Brain MRI Volumetry Differentiates Early Stages of Alzheimer's Disease From Normal Aging.
    Zhao W; Luo Y; Zhao L; Mok V; Su L; Yin C; Sun Y; Lu J; Shi L; Han Y
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):354-364. PubMed ID: 31480984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer's disease and predicts cerebral amyloidosis.
    Li TR; Yao YX; Jiang XY; Dong QY; Yu XF; Wang T; Cai YN; Han Y
    Alzheimers Res Ther; 2022 May; 14(1):66. PubMed ID: 35550625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between methylation of BIN1 promoter in peripheral blood and preclinical Alzheimer's disease.
    Hu H; Tan L; Bi YL; Xu W; Tan L; Shen XN; Hou XH; Ma YH; Dong Q; Yu JT
    Transl Psychiatry; 2021 Feb; 11(1):89. PubMed ID: 33531457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.